Announcements Trials
Browse Landscape

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Neoplasm Metastasis 3Breast Neoplasms 3

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 60palbociclib 37Trastuzumab 31Letrozole 26Immunohistochemistry 26Drug Therapy 24Anastrozole 24Radiotherapy 21Gene Expression Profiling 20Amplified Fragment Length Polymorphism Analysis 20Mastectomy, Segmental 19Biopsy 19Tamoxifen 18exemestane 17Interviews as Topic 17ribociclib 16Mastectomy 16Fulvestrant 16Paclitaxel 15Magnetic Resonance Spectroscopy 15Psychiatric Rehabilitation 14High-Energy Shock Waves 14Polymerase Chain Reaction 13Observation 13Microarray Analysis 13Capecitabine 13trastuzumab deruxtecan 12Neoadjuvant Therapy 12Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms × Biological Assay × Clear all
NCT00551278 2016-01-12

Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer

Janssen Diagnostics, LLC

Completed
80 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595023 2016-01-12

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

Janssen Diagnostics, LLC

Terminated
233 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00595296 2016-01-12

GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study

Janssen Diagnostics, LLC

Terminated
461 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡